Hypophosphatemia in Diabetic Ketoacidosis During Intensive Care Admission
Medical Sciences · 2026-05-12 · 14 (2) · 249
DOI: 10.3390/medsci14020249 ↗At a glance
Multizentrische Studie in Medical Sciences, published online on 2026-05-12. Written by Nicolas A Sieben and 13 co-authors. Institution: Mater Public Hospital, Brisbane, QLD 4101, Australia. Major MEDLINE topics: Diabetic Ketoacidosis, Hypophosphatemia, Critical Care. 33 references. The full text is freely available (open access, CC BY 4.0).
Topics: Intensivpflege
Abstract (original language)
Introduction
Diabetic ketoacidosis (DKA) is a common complication of diabetes mellitus characterized by metabolic acidosis, ketogenesis, hypovolemia, hyperglycemia, and electrolyte depletion. During treatment of DKA with intravenous fluids and insulin, some electrolyte disturbances can worsen. Hypophosphatemia is one such electrolyte disturbance that has not been well characterized in patients with severe DKA requiring Intensive Care Unit (ICU) admissions. This study sought to evaluate the incidence, severity, associations, and outcomes of hypophosphatemia in DKA.
Methods
This retrospective multicenter study was conducted across DKA admissions to Queensland ICUs from 2016 to 2021. Adult patients (>18 years) requiring ICU admission for management of DKA were included in this study. Patients with DKA were stratified by lowest recorded phosphate level as: normal ≥ 0.80 mmol/L, mild 0.50–0.79 mmol/L, moderate 0.30–0.49 mmol/L and severe < 0.3 mmol/L. Patient demographics, comorbidities, ICU-related supports, and medications (including fluid, insulin administration, phosphate, and other electrolyte replacement) were collected. Univariate analysis was performed between hypophosphatemia severity and normophosphatemia subgroups to determine risk factors, outcomes, replacement, and progression of hypophosphatemia in the ICU. Phosphate replacement and administered insulin was compared to nadir serum phosphate level. Multivariate analysis and linear regression were performed to identify risk factors for the development of hypophosphatemia.
Results
A total of 842 admissions of 669 unique patients due to DKA were included; 436 of 842 (51.8%) admissions maintained normophosphatemia in the ICU, while 220 (26.1%, n = 220/842) had mild hypophosphatemia, 124 (14.7%, n = 124/842) had moderate hypophosphatemia and 62 (7.4%, n = 62/842) had severe hypophosphatemia. Patients with higher BMI, higher APACHE II/III score, cerebrovascular disease and all blood gas parameters (excluding PaO2) were found to have more severe hypophosphatemia. Lower serum phosphate was associated with greater replacement and greater insulin administration per kilogram body weight. ICU length of stay, hospital length of stay and mortality were not affected by degree of hypophosphatemia (p > 0.05). Linear regression revealed that standard base excess was strongly associated with the development of hypophosphatemia (β = 0.02, 95% CI 0.01–0.02, p < 0.001).
Conclusions
Increasing severity of hypophosphatemia was associated with increasing severity of DKA. Increased ICU length of stay was related to increased severity of hypophosphatemia.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Mater Public Hospital, Brisbane, QLD 4101, Australia.
- Royal Brisbane and Women's Hospital, Metro North Hospital and Health Services, Brisbane, QLD 4029, Australia.
- Intensive Care Unit, Cairns Hospital, Cairns, QLD 4870, Australia.
- Intensive Care Unit, Redcliffe Hospital, Redcliffe, QLD 4020, Australia.
- Faculty of Medicine, Mayne Academy of Critical Care, University of Queensland, St Lucia, Brisbane, QLD 4072, Australia.
- Intensive Care Unit, Princess Alexandra Hospital, Woolloongabba, QLD 4102, Australia.
ORCID profiles: Sebastiaan Blank, Kyle C White, Kevin B Laupland, Antony Attokaran, Aashish Kumar, Peter Garrett, Mahesh Ramanan
Cite
APA
Sieben, N. A., Blank, S., Tabah, A., White, K. C., Laupland, K. B., Edwards, F., Attokaran, A., Luke, S., Kumar, A., Whebell, S., Parmar, D., McCullough, J., Garrett, P., & Ramanan, M. (2026). Hypophosphatemia in Diabetic Ketoacidosis During Intensive Care Admission. Medical Sciences, 14(2), 249. https://doi.org/10.3390/medsci14020249
Vancouver
Sieben NA, Blank S, Tabah A, White KC, Laupland KB, Edwards F, et al. Hypophosphatemia in Diabetic Ketoacidosis During Intensive Care Admission. Medical Sciences. 2026;14(2):249. doi:10.3390/medsci14020249
BibTeX
@article{Sieben2026,
author = {Sieben, Nicolas A and Blank, Sebastiaan and Tabah, Alexis and White, Kyle C and Laupland, Kevin B and Edwards, Felicity and Attokaran, Antony and Luke, Stephen and Kumar, Aashish and Whebell, Stephen and Parmar, Dinesh and McCullough, James and Garrett, Peter and Ramanan, Mahesh},
title = {Hypophosphatemia in Diabetic Ketoacidosis During Intensive Care Admission},
journal = {Medical Sciences},
year = {2026},
volume = {14},
number = {2},
pages = {249},
doi = {10.3390/medsci14020249}
}
EUVIMED